Evli Yrityslaina vs UBS Lux Equity Fund Biotech USD

Security

Evli Corporate Bond B
Fee

0.97%
ISIN

FI0008801097
Holdings

17

Security

UBS Lux Equity Fund Biotech USD P-acc
Fee

2.25%
ISIN

LU0069152568
Holdings

5

Fund Holdings

We have information about 17 holdings in Evli Yrityslaina, where the largest holding is Societe Generale (1.79), followed by Eurogrid (1.42) and Redeia (1.17). In comparison with UBS Lux Equity Fund Biotech USD, we have 7 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66).

All Holdings

Here we compare the holdings in Evli Yrityslaina and UBS Lux Equity Fund Biotech USD.

Evli Yrityslaina	UBS Lux Equity Fund Biotech USD
1. Societe Generale SA 1.79 %	1. Regeneron Pharmaceuticals Inc 10.04 %
2. Eurogrid GmbH 1.42 %	2. Moderna Inc 9.21 %
3. Redeia Corporacion SA 1.17 %	3. Gilead Sciences Inc 4.66 %
4. Mölnlycke Holding AB 1.13 %	4. BioNTech SE 4.13 %
5. Statnett SF 1.08 %	5. Karuna Therapeutics Inc 3.75 %
6. Telenor ASA 1.07 %	-
7. Ellevio AB 1.07 %	-
8. BNP Paribas SA 1.05 %	-
9. Allianz SE 0.97 %	-
10. Akelius Residential Property Finance BV 0.97 %	-
11. Siemens Financieringsmaatschappij NV 0.96 %	-
12. Loomis B 0.95 %	-
13. SpareBank 1 Sør-Norge ASA 0.95 %	-
14. TenneT Holding BV 0.94 %	-
15. NTI Group Holding ApS 0.88 %	-
16. Kojamo Oyj 0.85 %	-
17. Commerzbank AG 0.83 %	-

The list of fund holdings was last updated on September 10, 2025.